Interact to see
Advertisement
Advertisement
RYEAX vs VENAX
RYEAX vs VENAX Comparison
Open Charts RYEAX vs VENAX
RYEAX vs VENAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
RYEAX vs. VENAX commentary
Jul 12, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYEAX is a Buy and VENAX is a Buy.
FUNDAMENTALS
Fundamentals
VENAX has more cash in the bank: 11.1B vs. RYEAX (44.9M). VENAX pays higher dividends than RYEAX: VENAX (2.68) vs RYEAX (2.34). RYEAX was incepted earlier than VENAX: RYEAX (28 years) vs VENAX (22 years). RYEAX (1.67) is less costly to investors than VENAX (0.09). RYEAX is a more actively managed with annual turnover of: 534.00 vs. VENAX (11.00). RYEAX has a lower initial minimum investment than VENAX: RYEAX (2500) vs VENAX (100000). RYEAX annual gain was more profitable for investors over the last year : 31.61 vs. VENAX (24.35). RYEAX (111.87) and VENAX (108.57) have equivalent 5 years return.
| RYEAX | VENAX | RYEAX / VENAX | |
| Total Expense Ratio | 1.62 | 0.09 | 1,800% |
| Annual Report Gross Expense Ratio | 1.67 | 0.09 | 1,856% |
| Fund Existence | 28 years | 22 years | - |
| Gain YTD | 25.797 | 22.906 | 113% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 100000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 44.9M | 11.1B | 0% |
| Annual Yield % from dividends | 2.34 | 2.68 | 87% |
| Returns for 1 year | 31.61 | 24.35 | 130% |
| Returns for 3 years | 38.32 | 33.54 | 114% |
| Returns for 5 years | 111.87 | 108.57 | 103% |
| Returns for 10 years | 62.59 | 60.24 | 104% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FFIMX | 23.59 | 0.12 | +0.52% |
| Fidelity Advisor Asset Manager 50% I | |||
| MGRFX | 17.24 | N/A | N/A |
| MassMutual Mid Cap Growth R5 | |||
| THPBX | 25.82 | N/A | N/A |
| BNY Mellon Balanced Opportunity J | |||
| TISVX | 19.41 | N/A | N/A |
| Transamerica International Sm Cp Val I | |||
| LYFCX | 18.66 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare C | |||